NVRO
NVRO Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Forecast
Insiders
Institutions
Government
Ownership
News
Income
Balance Sheet
Cash Flow
Revenue Breakdown
Recent trades of NVRO by members of U.S. Congress
NVRO Stock Insider Trading Activity
Follow @QuiverQuant for major insider updates
Closing Price
Purchase
Sale
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
NVRO Stock Institutional Owners
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
NVRO Derivatives Institutional Owners
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes by institutional investors
Quarterly net insider trading by NVRO's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Backtest Start Date
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Subscribe to Quiver Premium for insider trading alerts
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$40,000 Apr 17, 2025 Issue: Medicare/Medicaid
-
$40,000 Jan 16, 2025 Issue: Medicare/Medicaid
-
$40,000 Oct 17, 2024 Issue: Medicare/Medicaid
-
$40,000 Jul 15, 2024 Issue: Medicare/Medicaid
-
$40,000 Apr 17, 2024 Issue: Medicare/Medicaid
-
$40,000 Oct 20, 2023 Issue: Medicare/Medicaid
-
$40,000 Jul 20, 2023 Issue: Medicare/Medicaid
-
$10,000 Jul 20, 2020 Issue: Medicare/Medicaid
-
$30,000 Jun 03, 2020 Issue: Medicare/Medicaid
-
$30,000 Jan 21, 2020 Issue: Medicare/Medicaid Taxation/Internal Revenue Code
-
$30,000 Oct 18, 2019 Issue: Taxation/Internal Revenue Code Medicare/Medicaid
-
$30,000 Jul 12, 2019 Issue: Medicare/Medicaid
-
$30,000 Apr 04, 2019 Issue: Medicare/Medicaid
-
$40,000 Jan 09, 2019 Issue: Medicare/Medicaid
-
$40,000 Oct 10, 2018 Issue: Medicare/Medicaid
-
$50,000 Jul 17, 2018 Issue: Health Issues
-
$40,000 Jul 09, 2018 Issue: Medicare/Medicaid
-
$30,000 Jan 19, 2018 Issue: Health Issues Medicare/Medicaid
Estimated quarterly lobbying spending
NVRO Revenue by Segment or Geography
By Segment
By Geography
NVRO Income Statement
NVRO Balance Sheet
NVRO Cash Flow
U.S. Patents
New patents grants
-
Patent Title: High frequency stimulation for treating sensory and/or motor deficits in patients with spinal cord injuries and/or peripheral polyneuropathy, and associated systems and methods Feb. 18, 2025
-
Patent Title: Variable amplitude signals for neurological therapy, and associated systems and methods Feb. 11, 2025
-
Patent Title: Neurological stimulation lead anchors and associated tools, and methods Feb. 04, 2025
-
Patent Title: Neurostimulation waveforms having a base component and a high frequency component, and associated systems and methods Nov. 05, 2024
-
Patent Title: Electrical therapy applied to the brain with increased efficacy and/or decreased undesirable side effects, and associated systems and methods Oct. 01, 2024
-
Patent Title: Methods and systems for disease treatment using electrical stimulation Jun. 04, 2024
-
Patent Title: Neurostimulation for treating sensory deficits, and associated systems and methods May. 21, 2024
-
Patent Title: Variable amplitude signals for neurological therapy, and associated systems and methods Apr. 02, 2024
-
Patent Title: Electrical therapy applied to the brain with increased efficacy and/or decreased undesirable side effects, and associated systems and methods Apr. 02, 2024
-
Patent Title: Devices for controlling spinal cord modulation for inhibiting pain, and associated systems and methods, including controllers for automated parameter selection Mar. 19, 2024
-
Patent Title: Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions Jan. 30, 2024
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods Jan. 30, 2024
-
Patent Title: Systems and methods for direct suppression of nerve cells Nov. 21, 2023
-
Patent Title: Motor function in spinal cord injury patients via electrical stimulation, and associated systems and methods Oct. 31, 2023
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods Oct. 17, 2023
-
Patent Title: Implanted pulse generators with reduced power consumption via signal strength/duration characteristics, and associated systems and methods Sep. 26, 2023
-
Patent Title: Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods Sep. 19, 2023
-
Patent Title: Paddle leads and delivery tools, and associated systems and methods Sep. 19, 2023
-
Patent Title: 2.4 ghz radio antenna for implanted medical devices, and associated systems and methods Jun. 27, 2023
-
Patent Title: Efficient use of an implantable pulse generator battery, and associated systems and methods Apr. 25, 2023
-
Patent Title: External neurostimulator Apr. 25, 2023
-
Patent Title: Sensory threshold adaptation for neurological therapy screening and/or electrode selection, and associated systems and methods Mar. 14, 2023
-
Patent Title: Treatment of congestive heart failure with electrical stimulation, and associated systems and methods Mar. 07, 2023
-
Patent Title: Ramped therapeutic signals for modulating inhibitory interneurons, and associated systems and methods Feb. 28, 2023
-
Patent Title: Power control circuit for sterilized devices, and associated systems and methods Feb. 07, 2023
-
Patent Title: Therapeutic modulation to treat blood glucose abnormalities, including type 2 diabetes, and/or reduce hba1c levels, and associated systems and methods Dec. 27, 2022
-
Patent Title: Variable amplitude signals for neurological therapy, and associated systems and methods Oct. 04, 2022
-
Patent Title: Handheld remote controller Sep. 27, 2022
-
Patent Title: High frequency electromagnetic stimulation for modulating cells, including spontaneously active and quiescent cells, and associated systems and methods Sep. 20, 2022
-
Patent Title: Leads having sidewall openings, and associated systems and methods Aug. 23, 2022
-
Patent Title: Neurological stimulation lead anchors and associated tools, and methods Jul. 19, 2022
-
Patent Title: Systems and methods for positioning implanted devices in a patient Jul. 12, 2022
-
Patent Title: Neuromodulation for altering autonomic functions, and associated systems and methods May. 03, 2022
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain, including cephalic and/or total body pain with reduced side effects, and associated systems and methods Apr. 12, 2022
-
Patent Title: Charger controller Apr. 05, 2022
-
Patent Title: Autonomic nervous system control via high frequency spinal cord modulation, and associated systems and methods Feb. 15, 2022
-
Patent Title: Selective high frequency spinal cord modulation for inhibiting pain with reduced side effects, and associated systems and methods Jan. 25, 2022
-
Patent Title: Spinal cord modulation for inducing paresthetic and anesthetic effects, and associated systems and methods Jan. 25, 2022
-
Patent Title: Systems and methods for automatically programming patient therapy devices Dec. 14, 2021
-
Patent Title: 2.4 ghz radio antenna for implanted medical devices, and associated systems and methods Oct. 19, 2021
-
Patent Title: Treatment of neurodegenerative disease with high frequency stimulation, and associated systems and methods Sep. 21, 2021
-
Patent Title: Electrical therapy applied to the brain with increased efficacy and/or decreased undesirable side effects, and associated systems and methods Sep. 21, 2021
-
Patent Title: Lead insertion devices and associated systems and methods Aug. 31, 2021
-
Patent Title: Systems and methods for extending the life of an implanted pulse generator battery Aug. 17, 2021
-
Patent Title: Motor function in spinal cord injury patients via electrical stimulation, and associated systems and methods Jul. 13, 2021
-
Patent Title: Paddle leads and delivery tools, and associated systems and methods Apr. 20, 2021
-
Patent Title: Methods for forming implantable signal generators with molded headers Mar. 16, 2021
-
Patent Title: Power control circuit for sterilized devices, and associated systems and methods Mar. 02, 2021
-
Patent Title: Systems and methods for producing asynchronous neural responses to treat pain and/or other patient conditions Feb. 16, 2021
-
Patent Title: Medical device communication and charging assemblies for use with implantable signal generators, and associated systems and methods Feb. 16, 2021
Government Contracts
Federal grants, loans, and purchases
- $58,855 2024-06-17 00:00:00 Agency: Department of Veterans Affairs
- $58,855 2024-05-03 00:00:00 Agency: Department of Veterans Affairs
- $58,279 2024-01-26 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2024-01-23 00:00:00 Agency: None
- $38,950 2024-01-23 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2024-01-23 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2024-01-23 00:00:00 Agency: Department of Veterans Affairs
- $29,725 2023-12-18 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-11-24 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-11-03 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2023-10-25 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2023-10-25 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-09-25 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-09-25 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-09-09 00:00:00 Agency: Department of Veterans Affairs
- $43,024 2023-09-05 00:00:00 Agency: Department of Veterans Affairs
- $40,258 2023-08-18 00:00:00 Agency: Department of Veterans Affairs
- $37,900 2023-08-11 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-08-10 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-08-08 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2023-08-08 00:00:00 Agency: Department of Veterans Affairs
- $35,000 2023-08-01 00:00:00 Agency: Department of Veterans Affairs
- $38,950 2023-07-13 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-07-13 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-07-13 00:00:00 Agency: Department of Veterans Affairs
- $38,825 2023-07-12 00:00:00 Agency: Department of Veterans Affairs
- $44,200 2023-07-07 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-07-03 00:00:00 Agency: Department of Veterans Affairs
- $36,225 2023-05-31 00:00:00 Agency: Department of Veterans Affairs
- $36,300 2023-05-30 00:00:00 Agency: Department of Veterans Affairs
- $37,450 2023-05-19 00:00:00 Agency: Department of Veterans Affairs
- $29,725 2023-05-19 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-05-09 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-05-09 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-05-09 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-04-24 00:00:00 Agency: Department of Veterans Affairs
- $31,775 2023-04-17 00:00:00 Agency: Department of Veterans Affairs
- $46,225 2023-04-12 00:00:00 Agency: Department of Veterans Affairs
- $29,975 2023-04-07 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-03-31 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-03-31 00:00:00 Agency: Department of Veterans Affairs
- $27,875 2023-03-28 00:00:00 Agency: Department of Veterans Affairs
- $29,975 2023-03-24 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-03-17 00:00:00 Agency: Department of Veterans Affairs
- $36,950 2023-03-10 00:00:00 Agency: Department of Veterans Affairs
- $41,024 2023-02-27 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $41,024 2023-02-17 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $33,250 2023-01-18 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $44,350 2023-01-09 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $36,950 2022-12-30 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Government Contracts
Estimated quarterly amount awarded from public contracts
NVRO News
Recent insights relating to NVRO
CNBC Recommendations
Recent picks made for NVRO stock on CNBC
Top ETF Holders
ETFs with the largest estimated holdings in NVRO
NVRO Analyst Ratings
NVRO Stock Forecasts
...
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
NVRO Analyst Forecasts
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
Frequently Asked Questions
- Is $NVRO stock a Buy, Sell, or Hold?
- What is the price target for $NVRO stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
NVRO Top Shareholders
|
Shareholder
|
Shares Held
|
|---|
Frequently Asked Questions
- Who owns $NVRO stock?
- Who owns the most shares of $NVRO stock?
- What funds own $NVRO stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
NVRO Stock Smart Score
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?
Sign Up to view NVRO Smart Score
Score Breakdown
Bull Case vs Bear Case
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
Bulls Say:
The Bulls Say summary highlights positive aspects of the stock.
Bears Say:
The Bears Say summary points out potential risks and negative aspects of the stock.
Show More